Work

Mild Facial Paresis in a Recipient of Gam-COVID-Vac Vaccine: A Case Report

Year: 2022

Type: article

Abstract: Facial paralysis has been reported as a rare side effect of mRNA COVID-19 vaccines. The Gam-COVID-Vac was introduced in August 2020 in Russia. There was no report of facial paralysis in phase I to III clinical trials of the vaccine. To our knowledge, there is no post-marketing report of facial paresis with Gam-COVID-Vac vaccination to this date. The Gam-COVID-Vac vaccine has a reported efficacy of 90%, but its safety and efficacy have not been approved by international organizations to this date. Iran is among the countries using the Gam-COVID-Vac vaccine. Here, we present a case of mild facial paresis that occurred shortly after the Gam-COVID-Vac vaccine administration in a female healthcare worker.

Source: Clinical Medicine Insights Case Reports

DOI: 10.1177/11795476221129120

Authors: Negin Mahmoudi Hamidabad, Amir Reza Mafi, Meysam Abolmaali

Institutions: Iran University of Medical Sciences, Firoozgar General Hospital, Farabi Hospital, Tehran University of Medical Sciences

Language: English

Topic: Facial Nerve Paralysis Treatment and Research

Subfield: Clinical Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,500